AIIMS New Delhi has launched Therapeutic Drug Monitoring services for antiepileptic drugs Levetiracetam and Lamotrigine, aiming to provide affordable, precision-based epilepsy care and improve access ...

The global burden of epilepsy and seizure disorders has stimulated ongoing efforts to discover novel anticonvulsant agents with enhanced efficacy and safety profiles. Medicinal chemistry strategies ...

Epilepsy affects over 65 million people worldwide and one third of patients exhibit resistance to current therapies, driving a persistent need for novel anticonvulsant agents. Preclinical research ...

Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company currently focused on ...

Vitae 2026, a hallmark event recognizing research excellence across University of Utah Health, featured six rising-star ...

Millions rely on Medicare Part D, but many prescription drugs won't be covered in 2026. See which meds are excluded, why, and ...

Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company currently focused on developing therapies for Tuberous Sclerosis Complex (TSC)-related epilepsy, ...

LEVETIRACETAM appeared well tolerated for seizure prophylaxis in octogenarians after severe traumatic brain injury, with low ...

Filana Therapeutics, Inc. (NASDAQ: FLNA, "Filana Therapeutics", the "Company"), a biotechnology company currently focused on developing therapies for Tuberous ...